Skip to content

Clinical trials

Observational Lymphoma, Large B-Cell, Diffuse trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Observational Country / region: United States Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20051
20065
20072
20088
20095
20102
20111
20132
20173
20182
20191
20207
20217
20224
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated13
Recruiting9
Active, not recruiting5
Withdrawn3
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Vanderbilt-Ingram Cancer Center4
AIDS Malignancy Consortium3
City of Hope Medical Center3
Case Comprehensive Cancer Center2
Children's Oncology Group2
Mayo Clinic2
MorphoSys AG2
National Cancer Institute (NCI)2
OHSU Knight Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse66
Lymphoma, Non-Hodgkin38
Lymphoma, Follicular36
Burkitt Lymphoma33
Lymphoma32
Lymphoma, Mantle-Cell32
Precursor Cell Lymphoblastic Leukemia-Lymphoma31
Leukemia, Lymphocytic, Chronic, B-Cell30
Lymphoma, Large-Cell, Immunoblastic27
Lymphoma, B-Cell, Marginal Zone26

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.